Master
Heading
Commercialization of Biomedical Technologies Course
Content
An exciting new course opportunity titled 鈥淐ommercialization of Biomedical Technologies鈥 (GS 5109) will be offered at the Graduate School of Biomedical Sciences (GSBS) for the upcoming fourth term. The course will be sponsored by BCM Ventures and led by Dr. Michael Dilling and will feature guest lectures from business and venture leaders from BCM, the TMC and beyond. Auditing participants are welcome!
- Course Title: Commercialization of Biomedical Technologies (GS 5109)
- Course Director: Michael Dilling, PhD, CLP, Executive Leader in Commercialization and Technology Management, BCM Ventures
- Schedule: Thursdays, 2 - 3 p.m., March 14 - May 2
- Location: N317, Alkek Building, GSBS, 香港6合开奖结果
- Registration deadline: Feb. 23, 2024
Don't miss out on this valuable opportunity to expand your knowledge and network within the field of biomedical technologies. We look forward to your active participation.
Terms
Item Definition
This comprehensive guide provides detailed information on our commercialization pathways and processes, and the resources and services available to help you.
Heading
Recent Press Releases
Content
- (January 2024)
- (September 2022)
- 香港6合开奖结果 and Texas Children鈥檚 Hospital collaborates with Incepta Vaccines Ltd. to develop a COVID-19 vaccine for Bangladesh (November 2021)
- (May 2021)
